SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    World Health Organization, UNICEF, UNFPA, The World Bank. Trends in Maternal Mortality: 1990 to 2010. Geneva, Switzerland: World Health Organization; 2012.
  • 2
    Campbell OM, Graham W. Strategies for reducing maternal mortality: Getting on with what works. Lancet. 2006;368(9543):12841299.
  • 3
    World Health Organization. Making Pregnancy Safer: The Critical Role of the Skilled Birth Attendant (a Joint Statement by WHO, ICM and FIGO). Geneva, Switzerland: World Health Organization, Department of Reproductive Health and Research; 2004.
  • 4
    International Federation of Gynaecologists and Obstetricians. Prevention of Postpartum Haemorrhage with Misoprostol. London, UK: FIGO Secretariat; 2012.
  • 5
    World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Geneva, Switzerland: World Health Organization; 2012.
  • 6
    Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: A systematic review. Lancet. 2006;367(9516):10661074.
  • 7
    World Health Organization. World Health Report 2005: Making Every Mother and Child Count. Geneva, Switzerland: World Health Organization; 2005.
  • 8
    Begley C, Gyte G, Devane D, McGuire W, Weeks A. Active versus expectant management in the third stage of labor. Cochrane Database Syst Rev. 2011;(11). DOI: 10.1002/14651858.CD007412.pub3.
  • 9
    Prendiville W, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2007;(4). DOI: 10.1002/14651858.CD000007.
  • 10
    Chen M, Chang Q, Duan T, He J, Zhang L, Liu X. Uterine massage to reduce blood loss after vaginal delivery. Obstet Gynecol. 2013;122(2 Pt 1):290295.
  • 11
    Deneux-Tharaux C, Sentilhes L, Maillard F, Closset E, Vardon D, Lepercq J, et al. Effect of routine controlled cord traction as part of the active management of third stage labour on postpartum hemorrhage: Multicentre randomised controlled trial (TRACOR). BMJ. 2013;346(f1541):111.
  • 12
    Gulmezoglu AM, Lumbiganon P, Landoulsi S, Widmer M, Abdel-Aleem H, Festin M, et al. Active management of the third stage of labour with and without controlled cord traction: A randomised, controlled, non-inferiority trial. Lancet. 2012;379(9827):17211727.
  • 13
    McDonald S, Middleton P, Dowswell T, Morris P. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev. 2013;(7). DOI: 10.1002/14651858.CD004074.pub3.
  • 14
    Abdel-Aleem H, Singata M, Abdel-Aleem M, Mshweshwe N, Williams X, Hofmeyr J. Uterine massage to reduce postpartum hemorrhage after vaginal delivery. Int J Gynaecol Obstet. 2010; 111(1):3236.
  • 15
    Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labor. Cochrane Database Syst Rev. 2010;(4). DOI: 0.1002/14651858.CD001808.
  • 16
    Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad M, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: A randomised controlled trial. Lancet. 2006;368(9543):12481253.
  • 17
    Alfirevic Z, Blum J, Walraven G, Weeks A, Winikoff B. Prevention of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet. 2007;99(Suppl 2):S198S201.
  • 18
    Langenbach C. Misoprostol in preventing postpartum hemorrhage: A meta-analysis. Int J Gynaecol Obstet. 2006;92(1):1018.
  • 19
    Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum hemorrhage in homebirths in Pakistan: A randomised placebo-controlled trial. BJOG. 2011;118(3):353361.
  • 20
    Prata N, Gessessew A, Abraha A, Hoston M, Potts M. Prevention of postpartum hemorrhage: Options for home births in rural Ethiopia. Afr J Reprod Health. 2009;13(2):8795.
  • 21
    Walraven G, Blum J, Dampha Y, Sowe M, Morison L, Winikoff B, et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: A randomised controlled trial. BJOG. 2005;112(9):12771283.
  • 22
    FIGO Safe Motherhood and Newborn Health Committee. Prevention and treatment of postpartum hemorrhage in low resource settings. Int J Gynaecol Obstet. 2012;117(2):108118.
  • 23
    World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Hemorrhage. Geneva, Switzerland: World Health Organization; 2012.
  • 24
    World Health Organization. WHO Recommendations for Optimizing Health Workers’ Roles to Improve Access to Key Maternal and Newborn Health Interventions Through Task Shifting. Geneva, Switzerland: World Health Organization; 2012.
  • 25
    Smith JM, Gubin R, Holston MM, Fullerton JT, Prata N. Misoprostol for postpartum hemorrhage prevention at home birth: An integrative review of global implementation experience to date. BMC Pregnancy and Childbirth. 2013;13(44):111.
  • 26
    Central Statistical Agency [Ethiopia], ORC Macro. Ethiopia Demographic and Health Survey 2011. Addis Ababa, Ethiopia and Calverton, MD: Central Statistical Agency and ORC Macro; 2012.
  • 27
    Venture Strategies Innovations. Ethiopia takes important policy step of registering misoprostol for postpartum bleeding. June 11, 2010. Available at: http://vsinnovations.org/ethiopia-registration.html. Accessed March 26, 2013.
  • 28
    Ethiopia Federal Ministry of Health. Road Map for Accelerating the Reduction of Maternal and Newborn Morbidity and Mortality: 2011–2015. Addis Ababa, Ethiopia: Ethiopian Federal Ministry of Health; 2011.
  • 29
    Ethiopia Federal Ministry of Health. National Guideline for the Prevention and Initial Treatment of Postpartum Hemorrhage at Health Post and Community Level: Pocket Reference Book for Health Extension Workers. Addis Ababa, Ethiopia: Ethiopia Federal Ministry of Health; 2011.
  • 30
    Sibley LM, Tesfaye S, Desta BF, Frew AH, Kbede A, Mohammad H, Stover KE, et al. Improving maternal and newborn health care delivery in rural Amhara and Oromiya Regions of Ethiopia through the Maternal and Newborn Health in Ethiopia Partnership. J Midwifery Womens Health. 2014;59:S6S20.
  • 31
    Sibley L, Barry D, Spangler SA, Tesfaye S, Desta B, Gobezayehu A. A regional comparison of distribution strategies and women's awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya Regions of Ethiopia. J Midwifery Womens Health. 2014;59:S73S82.
  • 32
    MAXQDA;. MAXQDA Software for Qualitative Data Analysis. Berlin, Germany: VERBI Software-Consult-Sozialforschung GmbH; 1989–2013.
  • 33
    Miles MB, Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook. 2nd ed. Thousand Oaks, CA: Sage Publications; 1994.
  • 34
    Hafner T, Shiffman J. The emergence of global attention to health systems strengthening. Health Policy Plan. 2013;28:4150.
  • 35
    Oladapo O, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum hemorrhage. Cochrane Database Syst Rev. 2012;(2). DOI: 10.1002/14651858.CD009336.pub2.
  • 36
    Diadhiou M, Dieng T, Ortiz C, Mall I, Dione D, Sloan NL. Introduction of misoprostol for prevention of postpartum hemorrhage at the community level in Senegal. Int J Gynaecol Ostet. 2011;115(3):251255.
  • 37
    Rajbhandari S, Hodgins S, Sanghvi H, McPherson R, Pradhan YV, Baqui AH, et al. Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: Operations research study in Nepal. Int J Gynaecol Ostet. 2010;108(3):282288.
  • 38
    Sanghvi H, Ansari N, Prata NJV, Gibson H, Ehsan A, Smith JM. Prevention of postpartum hemorrhage at home birth in Afganistan. Int J Gynaecol Ostet. 2009;108(3):276281.
  • 39
    Sutherland T, Bishai DM. Cost-effectiveness of misoprostol and prenatal iron supplementation as maternal mortality interventions in home births in rural India. Int J Gynaecol Ostet. 2008;104(3):189193.
  • 40
    Prata N, Sreenivas A, Greig F, Walsh J, Potts M. Setting priorities for safe motherhood interventions in resource-scarce settings. Health Policy. 2009;94(1):113.
  • 41
    Countdown Working Group on Health Policy and Health Systems. Assessment of the health system and policy environment as a critical complement to tracking intervention coverage for maternal, newborn, and child health. Lancet. 2008;371(9620):12841293.
  • 42
    Shiffman J. Generating political priority for maternal mortality reduction in 5 developing countries. Am J Public Health. 2007;97(5):796803.
  • 43
    Woelk G, Daniels K, Cliff J, Lewin S, Sevene E, Fernandes B, et al. Translating research into policy: Lessons learned from eclampsia treatment and malaria control in three southern African countries. Health Res Policy Syst. 2009;7(31):114.
  • 44
    Spangler SA, Koski A, Armbruster D, Stanton C. Expanding postpartum hemorrhage prevention to the community in resource-poor contexts: Critical considerations and next steps. International Journal of Childbirth. 2011;1(1):3951.